Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess

Weimin Gao, Zhigang Xia, Tingfeng Zhou, Youlin Dong

Open source

DOI
10.3389/fphar.2025.1602276
Published
2025-06-24
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1602276,
  title = {Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess},
  author = {Weimin Gao and Zhigang Xia and Tingfeng Zhou and Youlin Dong},
  year = {2025},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2025.1602276},
  url = {https://doi.org/10.3389/fphar.2025.1602276}
}

RIS

TY  - JOUR
TI  - Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess
AU  - Weimin Gao
AU  - Zhigang Xia
AU  - Tingfeng Zhou
AU  - Youlin Dong
PY  - 2025
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2025.1602276
UR  - https://doi.org/10.3389/fphar.2025.1602276
ER  - 

APA

Gao, W., Xia, Z., Zhou, T., & Dong, Y. (2025). Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1602276

Source records